• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Alexandria Real Estate Equities

edit

Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science Industry®, is the largest owner and pre-eminent first-in-class real estate investment trust focused principally on science-driven cluster formation. Alexandria is the leading provider of real estate to the life science industry, and has an outstanding 11 year track record as a NYSE listed company with an approximate $5.2 billion total market capitalization (as of December 31, 2008).

Recent Milestones

edit

• 
  Alexandria Real Estate Equities invested in Cydan. (4/11/13)
  Posted 4/12/13 at 4:59am via businesswire.com
• 
  Alexandria Real Estate Equities invested in Theraclone Sciences. (3/25/13)
  Posted 3/25/13 at 8:12pm via finsmes.com
• 
  Alexandria Real Estate Equities invested in Oncofactor Corporation. (8/2/11)
  Posted 5/24/11 at 3:33am via onbiovc.com
• 
  Alexandria Real Estate Equities invested in Acylin Therapeutics. (1/11/11)
  Posted 1/19/11 at 9:44pm via onbiovc.com
• 
  Alexandria Real Estate Equities invested in Mirina. (4/26/10)
  Posted 4/26/10 at 12:42pm via xconomy.com
• 
  Alexandria Real Estate Equities invested in Theraclone Sciences. (3/17/10)
  Posted 7/22/10 at 7:17pm via xconomy.com
• 
  Alexandria Real Estate Equities invested in Metabolon. (12/7/09)
  Posted 12/7/09 at 9:47pm via onbiovc.com
• 
  Alexandria Real Estate Equities invested in Cambrios Technologies. (11/1/09)
  Posted 11/9/09 at 1:36am via venturebeat.com
• 
  Alexandria Real Estate Equities invested in BrainCells. (4/1/08)
  Posted 5/22/09 at 1:44pm via venturedeal.com
• 
  Alexandria Real Estate Equities invested in Cerulean Pharma. (1/3/08)
  Posted 12/19/09 at 2:37am via ceruleanrx.com
• 
  Alexandria Real Estate Equities invested in Allozyne. (10/26/07)
  Posted 3/11/10 at 8:10pm via allbusiness.com
• 
  Alexandria Real Estate Equities invested in BioRelix. (6/11/07)
  Posted 3/22/12 at 6:18pm via masshightech.com
• 
  Alexandria Real Estate Equities invested in nanosys. (11/9/05)
  Posted 10/1/10 at 12:52am

Investments

Videos

Sources

1. Cydan, a New Orphan Drug Accelerator, Launches with $16 Million Financing from Leading Investors NEA, Pfizer Venture Investments and Alexandria Real Estate Equities (businesswire.com) [edit]
2. Theraclone Sciences Closes $14M in Series B and Debt Financing (finsmes.com) [edit]
3. Oncofactor, Inc.: Series A $2.1M (onbiovc.com) [edit]
4. Acylin Therapeutics, Inc.: Series A $4.4M (onbiovc.com) [edit]
5. Mirina Nabs $3.9M (xconomy.com) [edit]
6. Theraclone Raises $1.5M (xconomy.com) [edit]
7. Metabolon, Inc.: Series C $6M (onbiovc.com) [edit]
8. Cambrios lands $14.5M for electronic display components (deals.venturebeat.com) [edit]
9. BrainCells Secures $20 Million More Series B Funding (venturedeal.com) [edit]
10. Tempo Pharmaceuticals Closes $8 Million in Series B Funding (ceruleanrx.com) [edit]
11. Allozyne, Inc., Closes $30 Million Series B Financing (allbusiness.com) [edit]
12. Nutmeg State biotech lands $25.8M in round one (masshightech.com) [edit]
13. EDGAR [edit]